ReCode in the News
Press Releases
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that
New Article Published in Science Highlights the Potential of ReCode Therapeutics’ Systemic Lung Delivery and CFTR Gene Correction
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of its Board of Directors
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that
Presentations
Aerosolized lipid nanoparticle/mRNA therapy to treat patients with Cystic Fibrosis
2023 Cilia, Mucus and Mucociliary Interactions GRC
Publications & Abstracts
Featured News
Unshackling genetic medicines by enabling delivery beyond the liver
Nature Biopharma Dealmakers
Media Contacts
ReCode Therapeutics
Erica Jefferson
[email protected]
The Grace Group
Tara Cooper
[email protected]
[email protected]
Investor Contact
Stern IR
AnneMarie Fields
[email protected]
[email protected]
Media Library
Download assets including ReCode’s logo, high-resolution headshots, and fact sheets.